VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 7 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,861,000 | +334.8% | 53,600 | +192.9% | 0.04% | +600.0% |
| Q4 2016 | $1,348,000 | -50.1% | 18,300 | -41.0% | 0.01% | -53.8% |
| Q3 2016 | $2,704,000 | +92.9% | 31,000 | +90.2% | 0.01% | +85.7% |
| Q2 2016 | $1,402,000 | +107.4% | 16,300 | +91.8% | 0.01% | +133.3% |
| Q1 2016 | $676,000 | -50.7% | 8,500 | -22.0% | 0.00% | -57.1% |
| Q4 2015 | $1,372,000 | -47.1% | 10,900 | -56.2% | 0.01% | -36.4% |
| Q3 2015 | $2,593,000 | -20.2% | 24,900 | -5.3% | 0.01% | -26.7% |
| Q2 2015 | $3,248,000 | +10.1% | 26,300 | +5.2% | 0.02% | +15.4% |
| Q1 2015 | $2,949,000 | +170.8% | 25,000 | +157.7% | 0.01% | +225.0% |
| Q3 2014 | $1,089,000 | -54.4% | 9,700 | -61.5% | 0.00% | -63.6% |
| Q2 2014 | $2,386,000 | -21.5% | 25,200 | -41.4% | 0.01% | -15.4% |
| Q1 2014 | $3,041,000 | -66.1% | 43,000 | -64.4% | 0.01% | -59.4% |
| Q4 2013 | $8,975,000 | +30.5% | 120,800 | +33.2% | 0.03% | +33.3% |
| Q3 2013 | $6,877,000 | -35.8% | 90,700 | -32.2% | 0.02% | -38.5% |
| Q2 2013 | $10,704,000 | – | 133,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 86,000 | $14,617,000 | 0.12% |
| SIMPLEX TRADING, LLC | 572 | $9,721,000 | 0.04% |
| JPMORGAN CHASE & CO | 66,600 | $11,319,000 | 0.00% |
| Allianz Asset Management GmbH | 3,900 | $663,000 | 0.00% |